Drugs affecting heart rate and arrhythmias/dysrhythmias Flashcards

1
Q

Arrhythmia

A

Absence of rhythm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dysrhythmia

A

Abnormal rhythm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the PSNS targets of the heart to control rate?

A

SA & AV nodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the chemical transmitter for PSNS control of heart rate?

What is the pathway?

What is the target tissue receptor?

A

Acetylcholine

  1. Preganglionic (SC)
  2. ACh onto postganglionic nicitonic receptors
  3. ACh onto muscarinc receptors (M2, GPCR)
  4. decreased HR

Muscarinic receptor (SA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does PSNS ACh stimulation do to heart rate?

A

Slows/bradycardia

ACh acts on M2R to decrease cAMP, opening K+ channels

K+ efflux slows Na+ and Ca2+ in, delays repolarization, tf takes longer for SA to reach threshold

**M2R is GPCR**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does SNS NA(+Adr) stimulation do to heart rate?

A

Increases/tachycardia, +contractility

NA acts on B1-aR to increase cAMP, opens Ca2+ channels, Ca2+ influx

Ca2+ influx in Phase 4 depolarization increases slope @ SA & AV - tf reach threshold faster, +firing rate, +conduction (rate and rhythm)

*can trigger dysrhythmias*

**B1-aR is GPCR(stimulatory)**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Atropine

A
  • Muscarinic antagonist
  • PSNS: blocks muscR, +HR (~60bpm)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

At rest, in normal healthy individuals, neural drive comes significantly from the

A

PSNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the SNS targets of the control of heart rate?

A

innervates SA node

conducting tussue

myocardial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the chemical transmitter for SNS control of heart rate?

What’s the ganglionic pathway?

What is the target tissue receptor?

A

Noreadrenaline (+ circulating adrenaline)

  1. Preganglionic neurons release ACh onto NicR
  2. Postganglionic neurons release NA onto B-aR (B1, GPCR) and myocardial cells
  3. +HR, +contractility
  • +circulating adrenaline also activates alpha and B-aRs, w/ different selectivity to

Beta-adrenoceptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the primary ativations by the SNS and PSNS at the heart?

A

PSNS - rate

SNS - rate and contractility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Noreadrenaline

A
  • SNS: at B-aR, +HR, +contractility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

alpha-1 adrenergic receptors

A

In smooth muscle (skin, sphincters, kidney, brain, bladder/uterus)

mediate contraction

activation = vasoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

alpha-2 adrenergic receptors

A

In brain and spinal cord

Vascular smooth muscle cells of certain blood vessels (skin arterioles, veins)

Binds NA from SNS postganglion and adrenaline from adrenal medulla

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

beta-1 adrenoceptors

A

Cardiac tissue, cerebral cortex, kidney

Increase CO (+HR at SA, +contractility)

+renin from juxtaglomerular cells

Lipolysis in adipose tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

beta-2 adrenoceptors

A

Smooth muscle (bronchi, GIT, uterus)

blood vessels (vasodilation)

Heart (+contraction, +CO, +HR @SA +contractility)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Proranalol

A
  • Beta blocker/antagonist
  • SNS: -HR (~10bpm)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is unique about the resting potential the SA node?

A

It’s unstable due to a unique leaky Na+ channel which causes an I-funny current and spontaneous depolarization (Phase 4)

~60mV - +20mV

19
Q

Ivabradine

A
  • Targets SA leaky Na+ channels
  • Trialled for angina - primary effect on rate
  • Potential use for some dysrhythmias
20
Q

Phase 0 of the SA action potential is

A

Ca2+ influx causing depolarization

(this is in contrast to ventricular APs where its Na+)

21
Q

Phase 3 of the SA AP is

A

repolarization

K+ out

Same as ventricular AP

22
Q

What is the resting membrane potential of the ventricular myocyte AP?

A

-90mV

Stable

Phase 4

23
Q

What is Phase 0 of the ventricular AP?

A

Depolarization by Na+ influx

(remember: pacemaker cells use Ca2+ here)

24
Q

What is Phase 1 of the ventricular AP?

A

Rapid repolarization by initial K+ efflux w/Ca2+ influx fighting K+ to extend AP

25
Q

What is Phase 2 of the ventricular AP?

A

Plateau; Ca+ in and K+ out

26
Q

What is Phase 3 of the ventricular AP?

A

Ca2+ gives up fighting against K+ coming out; tf get replarization by K+ efflux

27
Q

Symptoms of dysrhthmia are

A

Shortness of breath, fainting, fatigue, chest pain

28
Q

How does altered impulse formation cause dysrhythmia?

A
  • abnormal pacemaker cell function
  • abnormal AP generation (at sites other than SA)
  • due to: changes in ionic environment or electrochemical balance; fibrosis (leads to oedmea)
29
Q

How does altered impulse condiction cause dysrhythmia?

A
  • Conduction block: ventricles beat, nothing from SA –> generate their own rhythm, rely on AV; causes slower rate
  • Re-entry: circulation of electrical activity, sometimes localized; extra beats increase rate (Wolf-Parkinson-White: Bundle of Kent, extra pathway, can lead to re-entry)
30
Q

How does triggered activity cause dysrhythmia?

A
  • Early or late adter-depol, excessive SNS activation
  • Stray currents in refractory period cause EADs by some active Ca2+ channels letting Ca2+ in; NA can do this
  • Ca2+ overload can cause LADs in post-refractory relaxation phase (SNS overactivity)
31
Q

What are the 4 major classes of antidysrhythmics?

A
  • Na+ channel blockers
  • B-aR antagonists
  • K+ channel blockers
  • Ca2+ channel blockers
32
Q

What are the three types of Na+ channel blockers?

A
  • 1A: moderate
  • 1B: weak
  • 1C: strong
33
Q

How does a Class 1a Na+ channel blocker affect the ventricular AP?

A

e.g. quinidine

  • moderate/intermediate block
  • prolong repolarization
  • increased effective refractory period (ERP)
  • slows tachydys
34
Q

How does a Class 1b Na+ channel blocker affect ventricular AP?

A

e.g. lignocaine

  • Mild block
  • Shortens repolarization (K+ channel)
  • Decrease ERP
  • Affects contraction quality (smaller APs)
35
Q

Lignocaine

A
  • Class 1b (mild) Na+ block (shortens repolarization and ERP)
  • Local anaesthetic
  • Intravenous antiarrhythmatic (ER)
36
Q

How does a Class 1c Na+ channel blocker affect the ventricular AP?

A

e.g. flecainide

  • Strong block
  • Decreases slope of Phase 0 the most
  • Repolarization stays the same
  • No effect on ERP
37
Q

What is the main action of Na+ channel blockers on the ventricular AP?

A

Reduce the Phase 0 (depolarization) slope and tf the peak

Variably change ERP

38
Q

What is the main action of B-aR antagonists as antidysrhythmics?

A

Decrease rate and conduction

  • inhibit SNS influence
  • prevent B1aR effects on SA & AV
  • decrease sinus rate
  • decrease conduction velocity
  • decrease aberrant pacemaker activity
  • membrane stabilizing in Purkinje fibres (local anaesthetic type activity)
  • can block Na+ channels too
39
Q

What is the main action of K+ channel blockers as antidysrhythmics?

A

Delay Phase 3, prolong duration

  • Stop K+ leaving
  • Prolong AP through delayed Phase 3 repolarization
  • decrease incidence of re-entry
  • increase risk of triggered events (E/LADs) because prolonged Phase 3 allows greater potential Ca2+ interference
40
Q

What is the main action of Ca2+ channel blockers as antidysrhythmics?

A

Reduce rate and conduction at SA and AV nodes

  • Cardioselective: SA & AV tissue, Ca2+ channels
  • Stop initiation of AP
  • limit tachy
  • slow conduction velocity
  • increase refractoriness
41
Q

What are the adverse effects of B-aR antagonist antidysrhythmics?

A
  • bradycardia
  • reduced exercise capacity
  • hypotension
  • AV conduction block
  • bronchoconstriction
  • hypoglycemia
42
Q

Amiodarone

A
  • Blocks K+ (antidysrhythmic), Na+, Ca2+ channels
  • Blocks B-aR

Adverse effects:

  • reversible photosensitization
  • skin discolouration
  • thryroid problems
  • LT: pulmonary fibrosis
43
Q

What are the adverse effects of Ca2+ channel blocker antidysrhythmics?

A
  • facial flushing
  • peropheral oedema
  • dizziness
  • bradycardia
  • headache
  • nausea